Tag archive for ‘Antares Pharmaceuticals’
Antares Pharma: Acquisition by Halozyme
I am a little sad to see Antares sell out to Halozyme. I thought that the rubber was just starting to meet the road and that it was too early to consider selling out although this was always the likely long term outcome. Oh well, maybe management knows or fears something that I am not […]
Antares Pharmaceuticals: An Update on Key Issues (ATRS, Buy, $2.14)
Investment Thesis Antares (ATRS) common has been hit with a storm of concerns that has caused the stock to decline from about $4.50 in March of this year to a low of $1.94 in August. This note addresses these issues and how they affect my investment thinking. In almost every investment situation I have been […]